Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bain Capital Double Impact is Bain Capital’s dedicated impact investment strategy, focusing on equity investments in mission-driven middle market companies within healthcare, education/workforce, and sustainability, seeking both strong financial returns and measurable social/environmental impact. It is highly active and well-funded, with over $1.1 billion in assets under management as of March 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bain Capital Double Impact.